Philip Boyce

Aug 31, 2024 | onlinelibrary.wiley.com | Gin S Malhi |Erica Bell |Uyen Le |Philip Boyce

In a case of long-standing, complicated major depression, esketamine was added to typical therapeutic agents used to overcome non-response. This case exemplifies how even in severe depression that has failed to respond to extensive treatment with diverse interventions, substantive improvements remain possible. Thus, depression described as ‘treatment resistant’ should not necessarily be regarded as irremediable.

May 31, 2023 | onlinelibrary.wiley.com | Gin S Malhi |Erica Bell |Darryl Bassett |Philip Boyce

Abstract Objectives To extend current published guidance regarding the management of major depression in clinical practice, by examining complex cases that reflect real-world patients, and to integrate evidence and experience into recommendations. Methods The authors who contributed to recently published clinical practice guidelines were invited to identify important gaps in extant guidance.

May 29, 2023 | onlinelibrary.wiley.com | Gin S Malhi |Erica Bell |Philip Boyce |Roger Mulder

Since the RANZCP mood disorders guidelines1 (MDcpg2020) published recommendations for the use of psychological interventions to treat depression, some psychodynamic psychotherapists have raised concerns that we only included short-term psychodynamic psychotherapy (STPP) alongside other evidence-based psychological treatments such as cognitive behavioural therapy (CBT) for the treatment of major depression.